大幸薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2010/10/01 | 1,211 | 1,240 | 1,202 | 1,222 | +41 | +3.5% | 66,100 |
| 2010/09/30 | 1,270 | 1,270 | 1,180 | 1,181 | -78 | -6.2% | 100,600 |
| 2010/09/29 | 1,209 | 1,280 | 1,209 | 1,259 | +44 | +3.6% | 189,300 |
| 2010/09/28 | 1,178 | 1,247 | 1,163 | 1,215 | +66 | +5.7% | 225,000 |
| 2010/09/27 | 1,178 | 1,178 | 1,144 | 1,149 | +27 | +2.4% | 36,100 |
| 2010/09/24 | 1,131 | 1,136 | 1,122 | 1,122 | -27 | -2.3% | 56,500 |
| 2010/09/22 | 1,153 | 1,162 | 1,135 | 1,149 | -21 | -1.8% | 51,700 |
| 2010/09/21 | 1,170 | 1,189 | 1,156 | 1,170 | ±0 | ±0% | 52,500 |
| 2010/09/17 | 1,186 | 1,205 | 1,162 | 1,170 | -36 | -3% | 137,000 |
| 2010/09/16 | 1,139 | 1,222 | 1,116 | 1,206 | +68 | +6% | 315,000 |
| 2010/09/15 | 1,145 | 1,145 | 1,125 | 1,138 | -5 | -0.4% | 143,000 |
| 2010/09/14 | 1,188 | 1,188 | 1,141 | 1,143 | -73 | -6% | 177,100 |
| 2010/09/13 | 1,225 | 1,230 | 1,210 | 1,216 | -21 | -1.7% | 125,000 |
| 2010/09/10 | 1,227 | 1,246 | 1,195 | 1,237 | -8 | -0.6% | 285,100 |
| 2010/09/09 | 1,290 | 1,330 | 1,225 | 1,245 | +30 | +2.5% | 711,300 |
| 2010/09/08 | 1,367 | 1,627 | 1,193 | 1,215 | -122 | -9.1% | 2,430,600 |
| 2010/09/07 | 1,097 | 1,337 | 1,090 | 1,337 | +300 | +28.9% | 563,500 |
| 2010/09/06 | 1,001 | 1,037 | 994 | 1,037 | +59 | +6% | 71,100 |
| 2010/09/03 | 952 | 993 | 942 | 978 | +37 | +3.9% | 59,100 |
| 2010/09/02 | 942 | 952 | 935 | 941 | -11 | -1.2% | 42,600 |
| 2010/09/01 | 950 | 954 | 940 | 952 | -3 | -0.3% | 26,000 |
| 2010/08/31 | 1,000 | 1,000 | 945 | 955 | -43 | -4.3% | 60,800 |
| 2010/08/30 | 990 | 1,011 | 980 | 998 | +38 | +4% | 53,000 |
| 2010/08/27 | 925 | 980 | 925 | 960 | +20 | +2.1% | 52,500 |
| 2010/08/26 | 925 | 947 | 913 | 940 | +19 | +2.1% | 61,000 |
| 2010/08/25 | 913 | 937 | 913 | 921 | -11 | -1.2% | 43,500 |
| 2010/08/24 | 933 | 943 | 920 | 932 | -16 | -1.7% | 42,800 |
| 2010/08/23 | 965 | 977 | 932 | 948 | -28 | -2.9% | 74,100 |
| 2010/08/20 | 998 | 1,005 | 975 | 976 | -19 | -1.9% | 83,800 |
| 2010/08/19 | 1,000 | 1,007 | 985 | 995 | -6 | -0.6% | 81,500 |
| 2010/08/18 | 1,031 | 1,035 | 985 | 1,001 | -45 | -4.3% | 84,600 |
| 2010/08/17 | 1,040 | 1,051 | 1,030 | 1,046 | -1 | -0.1% | 26,900 |
| 2010/08/16 | 1,056 | 1,070 | 1,035 | 1,047 | -23 | -2.1% | 25,700 |
| 2010/08/13 | 1,040 | 1,088 | 1,040 | 1,070 | +15 | +1.4% | 43,700 |
| 2010/08/12 | 1,051 | 1,120 | 1,031 | 1,055 | -83 | -7.3% | 76,900 |
| 2010/08/11 | 1,150 | 1,160 | 1,137 | 1,138 | -42 | -3.6% | 36,300 |
| 2010/08/10 | 1,180 | 1,207 | 1,180 | 1,180 | -28 | -2.3% | 16,900 |
| 2010/08/09 | 1,213 | 1,228 | 1,198 | 1,208 | -27 | -2.2% | 20,100 |
| 2010/08/06 | 1,242 | 1,252 | 1,220 | 1,235 | -22 | -1.8% | 12,200 |
| 2010/08/05 | 1,199 | 1,257 | 1,198 | 1,257 | +56 | +4.7% | 46,700 |
| 2010/08/04 | 1,214 | 1,214 | 1,170 | 1,201 | -27 | -2.2% | 18,500 |
| 2010/08/03 | 1,250 | 1,250 | 1,216 | 1,228 | +1 | +0.1% | 14,700 |
| 2010/08/02 | 1,210 | 1,244 | 1,195 | 1,227 | -3 | -0.2% | 25,200 |
| 2010/07/30 | 1,278 | 1,280 | 1,230 | 1,230 | -41 | -3.2% | 37,900 |
| 2010/07/29 | 1,222 | 1,274 | 1,209 | 1,271 | +49 | +4% | 49,000 |
| 2010/07/28 | 1,178 | 1,228 | 1,156 | 1,222 | +51 | +4.4% | 68,600 |
| 2010/07/27 | 1,185 | 1,188 | 1,162 | 1,171 | -12 | -1% | 30,800 |
| 2010/07/26 | 1,152 | 1,199 | 1,152 | 1,183 | +32 | +2.8% | 58,200 |
| 2010/07/23 | 1,130 | 1,170 | 1,130 | 1,151 | +14 | +1.2% | 40,900 |
| 2010/07/22 | 1,145 | 1,145 | 1,110 | 1,137 | -16 | -1.4% | 43,800 |
3601～
3650
件表示中 / 3978件
類似銘柄と比較する
現在ご覧いただいている「大幸薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 大幸薬品 | 36,700円 | +0.1% | -70.9% | 0.00% | 61.37倍 | 2.31倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
| ステムリム | 32,600円 | - | - | 0.00% | - | 3.00倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| 扶桑薬 | 210,200円 | +1.6% | -12.7% | 4.28% | 7.81倍 | 0.54倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| ＣＡＮＢＡＳ | 96,600円 | - | - | 0.00% | - | 6.18倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
| キッズバイオ | 37,000円 | - | - | 0.00% | - | 13.17倍 |
|
北大発創薬ベンチャー。バイオ後続品を主力に、乳歯歯髄幹細胞（ＳＨＥＤ）用いた再生医療に力 |
市場注目の銘柄
チャート関連のコラム
